Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

AM Sheehy, NC Gaddis, JD Choi, MH Malim - Nature, 2002 - nature.com
Viruses have developed diverse non-immune strategies to counteract host-mediated
mechanisms that confer resistance to infection. The Vif (virion infectivity factor) proteins are …

The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif

AM Sheehy, NC Gaddis, MH Malim - Nature medicine, 2003 - nature.com
The human protein apolipoprotein B mRNA-editing enzyme–catalytic polypeptide-like-3G (APOBEC3G),
also known as CEM-15, mediates a newly described form of innate resistance …

The HIV-1 rev protein

VW Pollard, MH Malim - Annual review of microbiology, 1998 - annualreviews.org
▪ Abstract The nuclear export of intron-containing HIV-1 RNA is critically dependent on the
activity of Rev, a virally encoded sequence-specific RNA-binding protein. Rev shuttles …

The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA

MH Malim, J Hauber, SY Le, JV Maizel, BR Cullen - Nature, 1989 - nature.com
HUMAN immunodeficiency virus type 1 (HIV-1) replication requires the expression of two
classes of viral mRNA. The early class of HIV-1 transcripts is fully spliced and encodes viral …

[PDF][PDF] HIV-1 accessory proteins—ensuring viral survival in a hostile environment

MH Malim, M Emerman - Cell host & microbe, 2008 - cell.com
One of the features of primate immunodeficiency viruses (HIVs and SIVs) that distinguishes
them from other retroviruses is the array of "accessory" proteins they encode. Here, we …

HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology

M Emerman, MH Malim - Science, 1998 - science.org
Human immunodeficiency virus type–1 (HIV-1) manipulates fundamental host cell processes
in sophisticated ways to achieve optimum replicative efficiency. Recent studies have …

[HTML][HTML] Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

…, JD Edgeworth, SJD Neil, MH Malim… - Nature …, 2020 - nature.com
Antibody responses to SARS-CoV-2 can be detected in most infected individuals 10–15 d
after the onset of COVID-19 symptoms. However, due to the recent emergence of SARS-CoV-…

[HTML][HTML] DNA deamination mediates innate immunity to retroviral infection

…, IN Watt, MS Neuberger, MH Malim - Cell, 2003 - cell.com
CEM15/APOBEC3G is a cellular protein required for resistance to infection by virion infectivity
factor (Vif)-deficient human immunodeficiency virus (HIV). Here, using a murine leukemia …

[HTML][HTML] Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective …

…, M Harries, A Rigg, J Spicer, MH Malim… - The Lancet …, 2021 - thelancet.com
Background The efficacy and safety profiles of vaccines against SARS-CoV-2 in patients with
cancer is unknown. We aimed to assess the safety and immunogenicity of the BNT162b2 (…

Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control

…, L Liu, JJ Gentry, MH Malim… - Proceedings of the …, 1997 - National Acad Sciences
Members of the NF-κB/Rel and inhibitor of apoptosis (IAP) protein families have been
implicated in signal transduction programs that prevent cell death elicited by the cytokine tumor …